2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Roivant Sciences Ltd. | Director | 96,650,341 | Jan 15, 2025 |
| Health Sciences Holdings, LLC | — | 2,875,000 | May 9, 2019 |
| Salzmann Peter | CEO | 1,178,191 | Apr 17, 2025 |
| Wong Roderick | CEO | 902,498 | Dec 13, 2019 |
| Butchko Julia G. | Chief Development Officer | 440,959 | Aug 23, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 27, 2026 | Gloria Melanie | COO | Sell | 42.5 | -3,238 | -1.87% | ✗ | $90.2K |
| Jan 21, 2026 | Jan 23, 2026 | Stout Jay S | Chief Technology Officer | Sell | 45.0 | -1,977 | -0.99% | ✗ | $51.5K |
| Jan 7, 2026 | Jan 9, 2026 | Stout Jay S | Chief Technology Officer | Sell | 48.8 | -1,203 | -0.60% | ✗ | $31.9K |
| Dec 18, 2025 | Dec 19, 2025 | Van Tuyl Christopher | Chief Legal Officer | Sell | 40.0 | -10,813 | -6.73% | ✗ | $290.9K |
| Dec 12, 2025 | Dec 12, 2025 | Roivant Sciences Ltd. | Director | Buy | 100.0 | +16,666,666 | 17.24% | ✗ | $350M |
| Dec 1, 2025 | Dec 3, 2025 | Fromkin Andrew J. | Director | Sell | 12.5 | -22,249 | -20.58% | ✓ | $517.2K |
| Dec 1, 2025 | Dec 3, 2025 | Hughes Douglas J. | Director | Sell | 22.5 | -15,000 | -11.05% | ✓ | $348.7K |
| Nov 20, 2025 | Nov 21, 2025 | Gloria Melanie | COO | Sell | 40.0 | -12,626 | -6.78% | ✗ | $298.2K |
| Oct 22, 2025 | Oct 24, 2025 | Geffner Michael | Chief Medical Officer | Sell | 46.3 | -2,595 | -1.18% | ✗ | $49.4K |
| Oct 22, 2025 | Oct 24, 2025 | Stout Jay S | Chief Technology Officer | Sell | 46.3 | -2,520 | -1.24% | ✗ | $48K |
| Oct 8, 2025 | Oct 10, 2025 | Geffner Michael | Chief Medical Officer | Sell | 48.8 | -1,272 | -0.57% | ✗ | $20.7K |
| Oct 8, 2025 | Oct 10, 2025 | Stout Jay S | Chief Technology Officer | Sell | 48.8 | -1,585 | -0.77% | ✗ | $25.8K |
| Jul 28, 2025 | Jul 30, 2025 | Venker Eric | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 23, 2025 | Jul 25, 2025 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -2,805 | -1.35% | ✗ | $50.9K |
| Jul 23, 2025 | Jul 25, 2025 | Geffner Michael | Chief Medical Officer | Sell | 46.3 | -2,385 | -1.06% | ✗ | $43.3K |
| Jul 9, 2025 | Jul 11, 2025 | Geffner Michael | Chief Medical Officer | Sell | 48.8 | -1,160 | -0.51% | ✗ | $20K |
| Jul 9, 2025 | Jul 11, 2025 | Stout Jay S | Chief Technology Officer | Sell | 48.8 | -1,519 | -0.73% | ✗ | $26.2K |
| May 1, 2025 | May 5, 2025 | Girao Tiago | CFO | Neutral | 90.0 | +208,388 | 100.00% | ✗ | - |
| May 1, 2025 | May 5, 2025 | Bauer Jake | Director | Neutral | 90.0 | +25,016 | 100.00% | ✗ | - |
| May 1, 2025 | May 5, 2025 | Susman Robert Graham | Director | Neutral | 90.0 | +25,016 | 100.00% | ✗ | - |
| Apr 28, 2025 | Girao Tiago | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 28, 2025 | Bauer Jake | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 28, 2025 | Susman Robert Graham | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 23, 2025 | Apr 25, 2025 | Stout Jay S | Chief Technology Officer | Sell | 48.8 | -1,925 | -0.91% | ✗ | $28.5K |
| Apr 23, 2025 | Apr 25, 2025 | Geffner Michael | Chief Medical Officer | Sell | 46.3 | -2,349 | -1.03% | ✗ | $34.7K |
| Apr 16, 2025 | Apr 17, 2025 | Barnett Eva Renee | CFO | Sell | 48.8 | -2,993 | -0.75% | ✗ | $44.6K |
| Apr 16, 2025 | Apr 17, 2025 | Salzmann Peter | CEO | Sell | 45.0 | -8,321 | -0.70% | ✗ | $123.9K |
| Apr 9, 2025 | Apr 11, 2025 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -5,004 | -2.31% | ✗ | $65K |
| Apr 9, 2025 | Apr 11, 2025 | Geffner Michael | Chief Medical Officer | Sell | 42.5 | -6,169 | -2.64% | ✗ | $80.1K |
| Apr 9, 2025 | Apr 11, 2025 | Barnett Eva Renee | CFO | Sell | 42.5 | -11,063 | -2.69% | ✗ | $143.7K |
| Apr 9, 2025 | Apr 11, 2025 | Salzmann Peter | CEO | Sell | 40.0 | -28,094 | -2.31% | ✗ | $364.9K |
| Apr 1, 2025 | Apr 3, 2025 | Van Tuyl Christopher | Chief Legal Officer | Neutral | 90.0 | +50,787 | 46.19% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Gloria Melanie | COO | Neutral | 90.0 | +76,181 | 69.28% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Stout Jay S | Chief Technology Officer | Neutral | 90.0 | +76,181 | 54.42% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Geffner Michael | Chief Medical Officer | Neutral | 90.0 | +101,574 | 76.77% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Barnett Eva Renee | CFO | Neutral | 90.0 | +88,878 | 27.61% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Salzmann Peter | CEO | Neutral | 90.0 | +265,820 | 28.02% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Pande Atul | Director | Neutral | 90.0 | +16,188 | 15.18% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Hughes Douglas J. | Director | Neutral | 90.0 | +16,188 | 13.54% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Fromkin Andrew J. | Director | Neutral | 90.0 | +16,188 | 17.61% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | MIGAUSKY GEORGE V | Director | Neutral | 90.0 | +16,188 | 13.37% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Torti Frank | Director | Neutral | 90.0 | +199,365 | 31.36% | ✗ | - |
| Mar 7, 2025 | Mar 11, 2025 | Fromkin Andrew J. | Director | Sell | 28.8 | -8,000 | -8.01% | ✓ | $156.8K |
| Feb 19, 2025 | Feb 21, 2025 | Macias William L. | Chief Medical Officer | Sell | 48.8 | -2,055 | -0.57% | ✗ | $42.9K |
| Feb 19, 2025 | Feb 21, 2025 | Barnett Eva Renee | CFO | Sell | 45.0 | -2,814 | -0.87% | ✗ | $58.7K |
| Feb 19, 2025 | Feb 21, 2025 | Salzmann Peter | CEO | Sell | 40.0 | -15,439 | -1.60% | ✗ | $322.1K |
| Jan 22, 2025 | Jan 24, 2025 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -2,195 | -1.54% | ✗ | $51.8K |
| Jan 22, 2025 | Jan 24, 2025 | Geffner Michael | Chief Medical Officer | Sell | 42.5 | -2,657 | -1.97% | ✗ | $62.7K |
| Jan 15, 2025 | Jan 17, 2025 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -2,383 | -0.66% | ✗ | $56.8K |
| Jan 15, 2025 | Jan 17, 2025 | Barnett Eva Renee | CFO | Sell | 45.0 | -2,298 | -0.70% | ✗ | $54.8K |
| Jan 15, 2025 | Jan 17, 2025 | Salzmann Peter | CEO | Sell | 45.0 | -8,767 | -0.90% | ✗ | $208.9K |
| Jan 13, 2025 | Jan 15, 2025 | Roivant Sciences Ltd. | Director | Buy | 100.0 | +16,845,010 | 21.11% | ✗ | $336.9M |
| Jan 8, 2025 | Jan 10, 2025 | Barnett Eva Renee | CFO | Sell | 42.5 | -4,105 | -1.24% | ✗ | $98.9K |
| Jan 8, 2025 | Jan 10, 2025 | Salzmann Peter | CEO | Sell | 45.0 | -5,105 | -0.52% | ✗ | $123K |
| Dec 16, 2024 | Dec 18, 2024 | Van Tuyl Christopher | Chief Legal Officer | Neutral | 90.0 | +109,956 | 100.00% | ✗ | - |
| Dec 18, 2024 | Van Tuyl Christopher | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 2, 2024 | Dec 4, 2024 | Pande Atul | Director | Sell | 32.5 | -7,750 | -6.77% | ✓ | $221.2K |
| Dec 2, 2024 | Dec 4, 2024 | Hughes Douglas J. | Director | Sell | 37.5 | -5,425 | -4.34% | ✓ | $154.8K |
| Nov 20, 2024 | Nov 22, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 42.5 | -3,650 | -1.13% | ✗ | $92.9K |
| Nov 20, 2024 | Nov 22, 2024 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -3,353 | -0.92% | ✗ | $85.3K |
| Nov 20, 2024 | Nov 22, 2024 | Barnett Eva Renee | CFO | Sell | 42.5 | -4,174 | -1.24% | ✗ | $106.2K |
| Nov 20, 2024 | Nov 22, 2024 | Salzmann Peter | CEO | Sell | 40.0 | -16,692 | -1.68% | ✗ | $424.8K |
| Nov 18, 2024 | Nov 20, 2024 | Gloria Melanie | COO | Neutral | 90.0 | +109,956 | 100.00% | ✗ | - |
| Nov 20, 2024 | Gloria Melanie | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 23, 2024 | Oct 25, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 42.5 | -4,361 | -1.33% | ✗ | $128.8K |
| Oct 23, 2024 | Oct 25, 2024 | Geffner Michael | Chief Medical Officer | Sell | 42.5 | -3,189 | -2.31% | ✗ | $94.2K |
| Oct 23, 2024 | Oct 25, 2024 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -2,740 | -1.89% | ✗ | $80.9K |
| Oct 16, 2024 | Oct 18, 2024 | Salzmann Peter | CEO | Sell | 42.5 | -9,095 | -0.91% | ✗ | $261.8K |
| Oct 16, 2024 | Oct 18, 2024 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -3,188 | -0.87% | ✗ | $91.8K |
| Oct 16, 2024 | Oct 18, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 45.0 | -2,860 | -0.87% | ✗ | $82.3K |
| Oct 16, 2024 | Oct 18, 2024 | Barnett Eva Renee | CFO | Sell | 45.0 | -3,271 | -0.97% | ✗ | $94.2K |
| Oct 9, 2024 | Oct 11, 2024 | Barnett Eva Renee | CFO | Sell | 42.5 | -5,162 | -1.50% | ✗ | $152.6K |
| Oct 9, 2024 | Oct 11, 2024 | Salzmann Peter | CEO | Sell | 47.5 | -4,460 | -0.44% | ✗ | $131.8K |
| Aug 21, 2024 | Aug 23, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 45.0 | -3,295 | -0.99% | ✗ | $105K |
| Aug 21, 2024 | Aug 23, 2024 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -3,027 | -0.82% | ✗ | $96.4K |
| Aug 21, 2024 | Aug 23, 2024 | Barnett Eva Renee | CFO | Sell | 42.5 | -3,768 | -1.08% | ✗ | $120K |
| Aug 21, 2024 | Aug 23, 2024 | Butchko Julia G. | Chief Development Officer | Sell | 45.0 | -3,027 | -0.68% | ✗ | $96.4K |
| Aug 21, 2024 | Aug 23, 2024 | Salzmann Peter | CEO | Sell | 40.0 | -15,068 | -1.47% | ✗ | $480.1K |
| Jul 24, 2024 | Jul 26, 2024 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -2,813 | -1.90% | ✗ | $78.1K |
| Jul 24, 2024 | Jul 26, 2024 | Geffner Michael | Chief Medical Officer | Sell | 42.5 | -3,456 | -2.44% | ✗ | $95.9K |
| Jul 24, 2024 | Jul 26, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 42.5 | -4,015 | -1.19% | ✗ | $111.5K |
| Jul 17, 2024 | Jul 19, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 45.0 | -2,505 | -0.74% | ✗ | $74.4K |
| Jul 17, 2024 | Jul 19, 2024 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -3,044 | -0.81% | ✗ | $90.4K |
| Jul 17, 2024 | Jul 19, 2024 | Barnett Eva Renee | CFO | Sell | 45.0 | -3,123 | -0.89% | ✗ | $92.7K |
| Jul 17, 2024 | Jul 19, 2024 | Butchko Julia G. | Chief Development Officer | Sell | 45.0 | -2,867 | -0.64% | ✗ | $85.1K |
| Jul 17, 2024 | Jul 19, 2024 | Salzmann Peter | CEO | Sell | 42.5 | -8,685 | -0.84% | ✗ | $257.9K |
| Jul 9, 2024 | Jul 10, 2024 | Barnett Eva Renee | CFO | Sell | 42.5 | -4,747 | -1.34% | ✗ | $133.2K |
| Jul 9, 2024 | Jul 10, 2024 | Butchko Julia G. | Chief Development Officer | Sell | 51.3 | -1,527 | -0.34% | ✗ | $42.8K |
| Jul 9, 2024 | Jul 10, 2024 | Salzmann Peter | CEO | Sell | 47.5 | -4,619 | -0.45% | ✗ | $129.6K |
| May 22, 2024 | May 24, 2024 | Barnett Eva Renee | CFO | Sell | 42.5 | -4,042 | -1.12% | ✗ | $119.8K |
| May 22, 2024 | May 24, 2024 | Salzmann Peter | CEO | Sell | 40.0 | -16,163 | -1.54% | ✗ | $479.2K |
| May 22, 2024 | May 24, 2024 | Butchko Julia G. | Chief Development Officer | Sell | 45.0 | -3,247 | -0.72% | ✗ | $96.3K |
| May 22, 2024 | May 24, 2024 | Macias William L. | Chief Medical Officer | Sell | 45.0 | -3,247 | -0.86% | ✗ | $96.3K |
| May 22, 2024 | May 24, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 45.0 | -3,242 | -0.94% | ✗ | $96.1K |
| Apr 24, 2024 | Apr 26, 2024 | Geffner Michael | Chief Medical Officer | Sell | 42.5 | -3,261 | -2.25% | ✗ | $94.2K |
| Apr 24, 2024 | Apr 26, 2024 | Stout Jay S | Chief Technology Officer | Sell | 42.5 | -7,239 | -4.67% | ✗ | $209.2K |
| Apr 24, 2024 | Apr 26, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 42.5 | -3,963 | -1.14% | ✗ | $114.5K |
| Apr 17, 2024 | Apr 19, 2024 | Levine Mark S. | Chief Legal Officer | Sell | 40.0 | -9,827 | -2.75% | ✗ | $285.6K |
| Apr 17, 2024 | Apr 19, 2024 | Macias William L. | Chief Medical Officer | Sell | 42.5 | -8,280 | -2.15% | ✗ | $240.6K |
| Apr 17, 2024 | Apr 19, 2024 | Barnett Eva Renee | CFO | Sell | 40.0 | -12,253 | -3.30% | ✗ | $356K |